Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Coleman currently holds 30,389 shares of Axsome Therapeutics, Inc. (AXSM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Coleman has been a net seller of AXSM stock. They have purchased $866.8K and sold $7.2M worth of shares.
Mark Coleman's most recent insider trade was on Jun 10, 2026, when they sold 643 shares at $249.00 per share.
Mark Coleman serves as Executive at Axsome Therapeutics, Inc. (AXSM). They have executed 36 insider transactions totaling $8.1M over their tenure at the company.
Mark Coleman holds the position of Executive at Axsome Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Mark Coleman has shown a selling trading pattern, with $866.8K in total purchases and $7.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Coleman was on May 29, 2026, when they sold $1.4M worth of AXSM shares. This transaction involved 6,000 shares at $233.46 per share.
Mark Coleman currently owns 30,389 shares of Axsome Therapeutics, Inc. (AXSM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Coleman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Coleman has 36 Form 4 filings on record as an insider at Axsome Therapeutics, Inc..
Set alerts for Mark Coleman and 40,000+ other insiders.